Dr. Douglas Evans | Surgery | Best Researcher Award

Posted on by sciencefather

Dr. Douglas Evans | Surgery | Best Researcher Award

Dr. Douglas Evans, Medical College of Wisconsin, United States

Dr. Douglas B. Evans is a distinguished leader in surgical oncology and currently serves as Chair of the Department of Surgery at the Medical College of Wisconsin. His medical expertise focuses on pancreatic cancer and complex surgical oncology, where he has made significant contributions through his leadership and research. He is highly respected for his extensive work at prestigious institutions, including the University of Texas MD Anderson Cancer Center, where he previously held a tenured professorship. Dr. Evans’ commitment to advancing cancer research and improving patient care has earned him recognition nationally and internationally. He has served on multiple national advisory boards and contributed to various scientific committees. Dr. Evans’ work continues to impact the fields of surgery and oncology, enhancing the understanding and treatment of pancreatic cancer.

Professional Profile

scopus

google scholar

Summary of Suitability for the Research for Best Researcher Award

Dr. Douglas B. Evans, with his extensive background in surgical oncology and a distinguished career, is highly suited for the Research for Best Researcher Award. His leadership as Chair of the Department of Surgery at the Medical College of Wisconsin since 2009 demonstrates his commitment to advancing surgical practices and medical education. His impressive list of academic and clinical roles, including his tenure as a professor at the University of Texas M. D. Anderson Cancer Center, highlights his sustained contributions to the field of cancer research, particularly in pancreatic and thyroid cancers.

🎓 Education 

Dr. Douglas B. Evans received his foundational education at Oliver Ames High School in North Easton, Massachusetts. He then attended Bates College in Lewiston, Maine, where he earned his Bachelor of Science degree. His medical journey continued at Boston University School of Medicine, where he obtained his M.D. Following this, Dr. Evans pursued postgraduate training in surgery at Dartmouth-Hitchcock Medical Center, where he completed both his internship and residency in general surgery. His specialization in surgical oncology was honed during his fellowship at the University of Texas MD Anderson Cancer Center. This extensive academic background provided him with the expertise required to become a leading figure in the surgical treatment of pancreatic and gastrointestinal cancers. His licensures include multiple states such as Texas and Wisconsin, and he is board-certified by the American Board of Surgery, with recertifications reflecting his continued commitment to excellence in surgical practice.

💼  Experience 

Dr. Douglas B. Evans has an extensive career in surgical oncology, marked by significant leadership roles. He began as an Instructor in Surgery at Dartmouth Medical School and progressed to Teaching Associate at the University of Texas MD Anderson Cancer Center. At MD Anderson, Dr. Evans ascended from Assistant Professor to full Professor of Surgery, eventually securing the Hamill Foundation Distinguished Professorship in honor of Dr. Richard G. Martin, Sr. Since 2009, he has been the Chair of the Department of Surgery at the Medical College of Wisconsin, where he also holds the Ausman Family Foundation Chair. Dr. Evans’ career highlights include serving as Surgeon-in-Chief at Froedtert Hospital and contributing to numerous advisory boards and national committees. His experience and influence in academic surgery, particularly in pancreatic cancer research and treatment, have established him as a key figure in the surgical oncology field.

🏅 Awards and Honors 

Dr. Douglas B. Evans has received numerous awards and honors throughout his distinguished career in surgical oncology. Early recognition came with the Resident’s Publication Award in 1985, followed by the prestigious Thomas P. Almy Award in 1987. His dedication to teaching was acknowledged by multiple Outstanding Teacher Awards, notably in 1995 and 2003 at the University of Texas MD Anderson Cancer Center. In 1999, he was awarded the American College of Surgeons Traveling Fellowship. More recently, Dr. Evans was honored with the Andrew L. Warshaw Master Educator Award in 2014 from the Society for Surgery of the Alimentary Tract, as well as the Wisconsin Way Award in Medicine in 2018. In 2021, he was appointed to the Douglas B. Evans Chair for Surgical Research, a testament to his contributions to both clinical practice and academic surgery. In 2023, he received the Benjamin E. Mays Medal from Bates College, their highest alumni honor.

🌍 Research Focus

Dr. Douglas B. Evans’ research primarily focuses on the surgical treatment of pancreatic cancer and complex gastrointestinal cancers. His work has significantly advanced the understanding of pancreatic tumor biology and the development of surgical techniques to improve patient outcomes. He is particularly interested in translational research that bridges basic science discoveries and clinical applications. Dr. Evans has contributed to groundbreaking studies on the molecular mechanisms driving pancreatic cancer, enhancing the accuracy of surgical interventions and postoperative care. His research has been pivotal in the development of multi-disciplinary treatment approaches that combine surgery with chemotherapy and radiation therapy for pancreatic and other gastrointestinal cancers. As a renowned leader in his field, Dr. Evans has published extensively in high-impact medical journals, and his research efforts continue to shape the landscape of surgical oncology and improve the prognosis for cancer patients worldwide.

📖 Publication Top Notes

  • One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States
    • Citation: 5547
  • Management of Thyroid Nodules Detected at US: Society of Radiologists in Ultrasound Consensus Conference Statement
    • Citation: 1921
  • Medullary thyroid cancer: management guidelines of the American Thyroid Association
    • Citation: 1712
  • Cancer-associated stromal fibroblasts promote pancreatic tumor progression
    • Citation: 1310
  • Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy
    • Citation: 1012

Assoc. Prof. Dr. Hui Zhang | Artificial Intelligence | Industry Achievement Award

Posted on by sciencefather

Assoc. Prof. Dr. Hui Zhang | Artificial Intelligence | Industry Achievement Award

Assoc. Prof. Dr. Hui Zhang, Guizhou University of Finance and Economics, China

Hui Zhang is a distinguished senior engineer and associate professor at the School of Information, Guizhou University of Finance and Economics, China. With a Ph.D. in Computational Mathematics from Guizhou Normal University, Zhang has a diverse background spanning both academia and industry. His expertise ranges from computational mathematics to big data and cloud computing, having held prominent roles in R&D departments in China’s tech industry. Additionally, Zhang has served as a reviewer for prestigious journals, contributed to key projects, and holds multiple patents in data science and technology. His ongoing research and professional services make him a well-recognized expert in his field.

Professional Profile

scopus

orcid

Summary of Suitability for the Research for Industry Achievement Award

Dr. Hui Zhang demonstrates a unique combination of academic and industrial achievements, making him a strong candidate for the Research for Industry Achievement Award. His background in computational mathematics and computer science, coupled with his experience in R&D and leadership roles in the big data industry, aligns well with the award’s focus on impactful industrial contributions.

🎓    Education

Hui Zhang completed his Bachelor’s in Information and Computational Science from Guizhou Normal University in 2010, alongside a Bachelor’s in English Education. He pursued a Master’s in Computational Mathematics at the same institution from 2010 to 2013. Hui continued his academic journey by earning a Ph.D. in Computational Mathematics, focusing on innovative computational methods. His educational experience highlights a strong foundation in both mathematics and interdisciplinary learning, setting the stage for his research and teaching career at Guizhou University of Finance and Economics.

💼   Experience

Hui Zhang’s career includes a range of positions in both academia and industry. After completing his master’s degree, he worked as a Business Manager at the Postal Savings Bank of China. He then transitioned to academic research while pursuing his Ph.D., contributing to key projects at the Guizhou Key Laboratory of Information and Computing Science. In industry, Zhang served as a Senior R&D Engineer and later General Manager of the R&D Department at Guizhou-Cloud Big Data Industry Development Co. Since 2022, he has been an associate professor at Guizhou University of Finance and Economics and a postdoctoral researcher, continuing to innovate in computer science and data science fields.

🏅  Awards and Honors

Hui Zhang’s numerous recognitions include being a Review Expert for multiple academic and governmental bodies, such as the Guizhou Provincial Department of Science and Technology. His technical contributions have earned him industry accolades, and he was invited to join the Big Data Expert Committee of the China Computer Federation. Zhang has also been honored as an Industrial Mentor in Guizhou Province and contributed as an expert reviewer for the prestigious Alexandria Engineering Journal. His expertise in computational mathematics and data science has made him a sought-after advisor and collaborator.

🌍  Research Focus

Hui Zhang’s research focuses on computational mathematics, big data, and information systems, particularly in developing algorithms and systems for data processing and analysis. He has worked extensively on Pulsar Data Processing, contributing to the design and implementation of comparative analysis and visualization systems. His research extends into numerical analysis, with a focus on finite element methods for solving complex mathematical problems. Zhang’s interdisciplinary approach combines theoretical mathematics with practical applications in data science, making significant advances in these fields.

📖 Publication Top Notes

  1. Generalized picture fuzzy Frank aggregation operators and their applications
  2. A second-order accurate and unconditionally energy stable numerical scheme for nonlinear sine-Gordon equation
  3. Asymmetrical interactions driven by strategic persistence effectively alleviate social dilemmas
  4. A Certificateless Verifiable Bilinear Pair-Free Conjunctive Keyword Search Encryption Scheme for IoMT
  5. Deformations and Extensions of Modified λ-Differential 3-Lie Algebras

Dr. Rômulo Carleial | Zoology | Best Researcher Award

Posted on by sciencefather

Dr. Rômulo Carleial | Zoology | Best Researcher Award

Dr. Rômulo Carleial, Royal Botanic Gardens, Kew, United Kingdom

Rômulo Carleial is an evolutionary biologist based at the Royal Botanic Gardens, Kew, UK. His research spans sexual selection, conservation genetics, and the evolutionary dynamics of phenotypic plasticity. He has a strong academic foundation, having studied in renowned institutions like the University of Oxford and Yale University. Rômulo’s work explores the interplay between genetics and adaptation, contributing to critical conservation efforts. His commitment to science education is evident through his teaching roles in the UK and Brazil. He is passionate about understanding the evolutionary mechanisms that shape biodiversity, aiming to solve ecological challenges.

Professional Profile

orcid

Summary of Suitability for the Research for Best Researcher Award:

Rômulo Carleial demonstrates an exceptional profile for the Research for Best Researcher Award. His research spans multiple critical areas, including evolutionary biology, conservation, and genetics, with a focus on sexual selection, genetic plasticity, and conservation biology. His reflective statement highlights a deep engagement with contemporary scientific questions, such as the philosophical implications of the Extended Evolutionary Synthesis, showing thought leadership in evolutionary theory.

🎓 Education

Rômulo Carleial has a rich educational background, beginning with his B.S. in Biology from the Federal University of Minas Gerais, Brazil. He further pursued his academic journey with an MSc in Ecology and Wildlife Management, where he developed his expertise in evolutionary biology. His DPhil in Zoology from the University of Oxford deepened his understanding of genetics and sexual selection. Additionally, Rômulo gained valuable experience as a visiting researcher at Yale University and Florida International University, honing his skills in evolutionary and conservation science, contributing to his global scientific perspective.

💼 Experience

Rômulo Carleial’s experience is diverse and impactful, with a PDRA position at the Royal Botanic Gardens, Kew, UK, focusing on conservation genetics. He has served as a tutor at Oxford University, delivering lectures and conducting practical demonstrations. His international teaching experiences include delivering courses in Brazil and the UK, alongside fieldwork supporting biodiversity conservation. Rômulo’s work extends to community outreach, organizing science events and talks to promote evolutionary biology education. His scientific collaborations have led to numerous international presentations, further cementing his reputation in evolutionary and conservation sciences.

🏅Awards and Honors

Rômulo Carleial has received numerous prestigious awards. In 2022, he co-authored a DEFRA grant that secured £438,704 to investigate the genetic basis of AOD. He was also a recipient of CNPq DPhil and MSc international scholarships, which funded his advanced research at Oxford University. These scholarships, along with CAPES Science Without Borders funding, supported his studies and international collaborations. His ability to secure competitive grants and scholarships highlights his research excellence and commitment to advancing evolutionary biology and conservation.

🌍 Research Focus

Rômulo Carleial’s research focuses on the intersection of evolutionary biology, conservation, and genetics. His earlier work examined sexual selection and sexual dichromatism, while his current interests lie in understanding how genetics and phenotypic plasticity contribute to adaptive traits in organisms. His research on the genetic basis of plant resistance to pathogens, particularly in oak trees, aims to protect ecosystems from climate change and disease. He is also exploring the philosophical implications of the Extended Evolutionary Synthesis, focusing on organismal agency in evolution and its conservation biology impact.

 📖 Publications Top Notes

Circadian patterns in male sexual behaviour and female resistance in a polygynandrous bird
A first draft genome of holm oak (Quercus ilex subsp. ballota), the most representative species of the Mediterranean forest and the Spanish agrosylvopastoral ecosystem “dehesa”
Disentangling the causes of temporal variation in the opportunity for sexual selection
Temporal dynamics of competitive fertilization in social groups of red junglefowl (Gallus gallus) shed new light on avian sperm competition
Dynamic phenotypic correlates of social status and mating effort in male and female red junglefowl, Gallus gallus

David Monroy | Ocular Cancer | Best Researcher Award

Posted on by sciencefather

David Monroy | Ocular Cancer | Best Researcher Award

  David Monroy, University of Miami, United States

David Monroy is a dedicated researcher with a strong background in neurocritical care and ophthalmology research. A graduate of Florida International University with a Bachelor of Science in Biological Sciences, David has developed significant expertise through his involvement in cutting-edge research projects. He has contributed to impactful studies at the University of Miami’s Neurology and Bascom Palmer Eye Institute, co-authoring numerous publications in esteemed journals. His focus on ocular surface tumors and brain injury has earned him recognition in the medical research community. David is passionate about scientific discovery and its real-world applications, aiming to bridge the gap between research and patient care. He is currently expanding his knowledge in traumatic brain injuries and their long-term outcomes through ongoing projects. His collaborative spirit and dedication to ethical research practices have positioned him as a promising young researcher in the medical field.

Professional Profile

  • orcid

    Education :

    David Monroy earned his Bachelor of Science in Biological Sciences from Florida International University (FIU) in 2020, where he followed a pre-medical track. As a student at FIU, David participated in various research programs, including the SEA-PHAGES program, where he discovered and analyzed novel bacteriophages. His educational journey was marked by an honors-level academic experience, which equipped him with the critical thinking and technical skills necessary for scientific research. Additionally, his time at FIU fostered a deep interest in neurobiology and medical sciences, which laid the groundwork for his subsequent research into neurocritical care and ophthalmology. Throughout his studies, David developed a comprehensive understanding of biological systems, disease mechanisms, and medical treatments, all while maintaining a high standard of academic achievement. His undergraduate experiences have significantly influenced his career trajectory in medical research.

    Experience :

    David Monroy’s research career includes notable roles such as Neurocritical Care Research Associate at the University of Miami, where he currently supports clinical studies in the neurosurgical intensive care unit. His work involves ensuring adherence to ethical protocols, communicating with patient families, and contributing to impactful studies on traumatic brain injury. Previously, David participated in ophthalmology research at the Bascom Palmer Eye Institute, focusing on ocular surface tumors and diagnostic techniques. He has authored multiple manuscripts and presented research findings at conferences, demonstrating his ability to communicate complex data effectively. During his time at Florida International University, he interned in a Parkinson’s disease research lab, where he gained experience in laboratory techniques and the study of neurodegenerative diseases. David’s career reflects a commitment to advancing medical knowledge through both clinical and basic science research, with a focus on improving patient care outcomes.

    Awards and Honors :

    David Monroy’s research and academic excellence have earned him several accolades. His work at the University of Miami’s Department of Neurology has been recognized for its contributions to understanding traumatic brain injuries, leading to multiple poster presentations at the prestigious Neurocritical Care Society conferences. Additionally, his studies on ocular surface tumors at the Bascom Palmer Eye Institute have resulted in peer-reviewed publications and presentations at the Association for Research in Vision and Ophthalmology (ARVO) conference. David’s commitment to advancing scientific knowledge has been rewarded with co-authorship on high-impact medical papers, underscoring his role in groundbreaking discoveries. While at Florida International University, he was part of the honors college, a testament to his academic dedication. His volunteer efforts, particularly with underserved communities, have also been recognized, reflecting his commitment to both research and service.

    Research Focus :

    David Monroy’s research is primarily focused on neurocritical care and ophthalmology, with an emphasis on traumatic brain injury and ocular surface tumors. In neurocritical care, his work has centered on understanding the cognitive and motor dissociation in brain injury patients, as well as examining the causes of traumatic brain injuries across different demographics. His research aims to improve long-term patient outcomes through innovative treatments and monitoring techniques. In ophthalmology, David has explored the infectious etiology of conjunctival tumors and developed diagnostic modalities for ocular surface squamous neoplasia. His research seeks to enhance early detection and improve therapeutic interventions for patients with ocular diseases. By collaborating with multidisciplinary teams, David continues to contribute to research that bridges the gap between laboratory findings and clinical applications, ensuring that his work has a tangible impact on patient care.

    Publication Top notes :

    • 📘 Alvarez OP., Monroy D., Thura S., et al. Infectious Etiology of Conjunctival Tumors. Expert Review of Ophthalmology, 2024.
    • 👁️ Monroy D., Venkateswaran N., Matthews JL., et al. Conjunctival keratoacanthoma: a clinical and histopathological case series. Canadian Journal of Ophthalmology, 2024.
    • 🔬 Monroy D., Serrano A., Galor A., & Karp CL. Medical treatments for ocular surface squamous neoplasia. Eye, 2023.
    • 💀 Monroy D., Garcia J., Zarate SD., et al. Displaced humeral pathological fracture secondary to intraosseous hemangioma. Radiology Case Reports, 2022.

Arnulf Stenzl | Health Professions | Academic Excellence Award

Posted on by sciencefather

Prof Dr Arnulf Stenzl | Health Professions | Academic Excellence Award

Prof Dr Arnulf Stenzl, Universität Tübingen, Tübingen Deutschland ,Germany

Prof. Dr. Arnulf Stenzl is an Austrian-born urologist and global leader in urological oncology. He received his medical degree from Karl-Franzens University in Graz, Austria, in 1980 and subsequently trained in surgery and urology across Austria, Switzerland, and the United States. Since 2002, he has headed the Department of Urology at Eberhard-Karls University in Tübingen, Germany, where he oversees critical research on urological cancers. Prof. Stenzl’s contributions extend internationally, with membership in numerous editorial boards and global collaborations. He has played a pivotal role in shaping European urological policies as Secretary General of the European Association of Urology. His work has led to several groundbreaking patents in the field, furthering innovations in patient care.

Professional Profile

Education 

Prof. Dr. Arnulf Stenzl embarked on his academic journey in 1973 when he enrolled at Karl-Franzens University in Graz, Austria, where he earned his Doctor medicinae universalis (M.D.) in February 1980. His initial training spanned internal medicine, nephrology, and pathology at Landeskrankenhaus Klagenfurt and Karl-Franzens University. From 1984 to 1987, he undertook specialized training in urology, first at Karl-Franzens University, then further expanding his knowledge as a fellow in general urology and urologic oncology at the University of California, Los Angeles (UCLA). His education, which encompassed diverse fields such as trauma, vascular, and plastic surgery, provided him with a holistic understanding of medicine and surgery. His dedication to learning has been reflected in his ongoing research and innovative contributions to urology.

Experience 

Prof. Dr. Arnulf Stenzl has had a distinguished career spanning over three decades. After serving as an assistant professor at the University of Bern in Switzerland, he moved to the University of Innsbruck, Austria, where he eventually became vice-chairman of the Department of Urology. Since 2002, he has led the Department of Urology at Eberhard-Karls University Tübingen, Germany, overseeing the clinical, academic, and research arms of the institution. Prof. Stenzl has driven numerous groundbreaking research projects, collaborating with both academic and industrial partners. As Secretary General of the European Association of Urology, he has led European urological research and development initiatives. His expertise extends to cancer research, with numerous contributions to advancing treatment modalities for bladder and prostate cancer.

Awards and Honors 

Prof. Dr. Arnulf Stenzl’s career is marked by numerous prestigious awards and honors. He is an honorary member of several international urological societies, including the Bristol Urological Institute and the Canadian Urological Association. His service as President of the German Urological Association (2020-2021) highlights his leadership within the field. Additionally, his involvement as Chairman of the Scientific Congress Office for the European Association of Urology and his role on the Board of Directors of the European CanCer Organisation demonstrate his commitment to global urological advancement. Prof. Stenzl’s contributions to scientific literature have earned him multiple editorial board memberships. His innovative spirit is further evidenced by several patents, including implantable devices to treat urinary incontinence and risk prediction models for renal cell carcinoma.

Research Focus 

Prof. Dr. Arnulf Stenzl’s research is at the forefront of urological oncology, focusing on advanced treatment modalities for bladder and prostate cancers. His work delves into personalized cancer therapies, optimizing clinical outcomes through precision medicine approaches. A significant aspect of his research revolves around biomarker discovery and risk stratification, which aim to enhance early diagnosis and targeted treatment. He has contributed to pioneering studies in immunotherapy, including innovative techniques for bladder cancer surgery and the integration of novel hormonal therapies in prostate cancer treatment. Prof. Stenzl is also involved in collaborative research projects with industry, furthering the development of next-generation urological treatments. His innovative contributions have resulted in several patents, solidifying his standing as a leader in urological research and technology.

Publications top notes

  • Treatment Intensification With Novel Hormonal Therapy in Prostate Cancer 📚🧪
  • Sacituzumab Govitecan Efficacy in Urothelial Cancer 🧬🔬
  • Co-occurring BRCA2/SPOP Mutations and PARP Inhibitor Sensitivity 🧬⚕️
  • Epacadostat Plus Pembrolizumab for Urothelial Carcinoma 💉🧪
  • Impact of Teratoma on Survival in Germ Cell Cancer 🧫🩺
  • Sacituzumab Govitecan & Pembrolizumab in Urothelial Cancer 💊🧪
  • TROPHY-U-01 Study on Sacituzumab Govitecan in Metastatic Urothelial Cancer 🧬🔬
  • Efficacy of Darolutamide in Black Patients With Prostate Cancer ⚕️🩺
  • Alpha Emitter for Metastatic Castration-Resistant Prostate Cancer 🧬💉